Dealing with any form of cancer is a difficult experience. Whether it is battling the symptoms of the disease or the treatments, it is taxing on the human body.
Traditional forms of cancer treatments such as chemotherapy can sometimes even make a person feel worse than the disease itself. When this happens, it can be helpful to consider other treatment options.
Cancer research continues to produce new promising treatments each year. One of the newest treatments that is getting attention is known as low dose Naltrexone or LDN.
Read on to learn all about this new treatment and whether it may be right for you if you’re going through cancer treatment.
What Is Low Dose Naltrexone?
Low dose Naltrexone is a prescription drug that works by blocking opioid receptors which enhance your body’s natural immune system. Specifically, the drug targets these receptors to prevent cells from growing. This can help prevent certain tumors from expanding in the body.
It also interacts with the body’s natural endorphins which can affect pain relief, the growth of new cells, and the immune system overall. Endorphins also play a role in shaping your mood and emotional experiences.
The main goal of LDN is to prevent cells from replicating and thus spreading or growing a cancerous tumor. If the cancer growth can be controlled, it is easier to treat through other common means without fear of it spreading.
There many forms of cancer that this drug can potentially treat. Anything from breast, bladder, colon, liver, ovarian, pancreatic, throat and many other cancers are good candidates for treatment.
Current research also suggests low dose naltrexone can be used in combating other diseases such as hepatitis C, lupus, chronic fatigue syndrome, and Crohn’s disease. Even individuals dealing with alcoholism may consider using LDN with their treatment.
Since the drug is new, there’s a lot of current, ongoing research into the use, effectiveness, and side effects of LDN. The latest research suggests that the drug does, in fact, target the specific opioid receptors it is meant to inhibit.
More research is required to confirm the effectiveness of the drug. This means that there are many trials going on currently that may be open to individuals with certain forms of cancer.
Studies that have already be conducted continue to show promising results. One particular study reported that out of 450 cancer patients, nearly a quarter of them experienced a 75% reduction in their cancer mass. 60% of these patients became stable with their diseases.
Learning More About LDN
Deciding on any kind of cancer treatment isn’t an easy task. If you are in this position, you need to be sure to do your research on any potential treatment option. Low dose Naltrexone could be a good treatment option if you feel it is right for you.
Get as much information as you can about the drug in order to make the best decision for yourself.
For more information or updates on LDN and in the latest research, check out the rest of our blog.